Immatics is committed to making a meaningful impact on the lives of patients with cancer. We are the global leader in precision targeting of PRAME, a target expressed in more than 50 cancers. Our cutting-edge science and robust clinical pipeline form the broadest PRAME franchise with the most PRAME indications and modalities, spanning TCR T-cell therapies and TCR bispecifics. Read more about Immatics on our homepage: https://immatics.com/ Find us also on: Instagram: https://www.instagram.com/immatics/ YouTube: https://www.youtube.com/channel/UCv7uTpsGXvSNzwSX_xOtYSA Legal notice: https://immatics.com/imprint/
Looking for a particular Immatics employee's phone or email?
The Immatics annual revenue was $76.7 million in 2026.
Harpreet Singh is the Chief Executive Officer, Managing Director of Immatics.
523 people are employed at Immatics.
Immatics is based in Tuebingen, Baden-Wuerttemberg.
The NAICS codes for Immatics are [5417, 54, 54171, 541714, 541].
The SIC codes for Immatics are [87, 873].